Moderne Tumortherapien und ihre pulmonalen Nebenwirkungen
Author:
Publisher
Springer Science and Business Media LLC
Subject
Oncology
Link
https://link.springer.com/content/pdf/10.1007/s11654-021-00360-6.pdf
Reference41 articles.
1. Foth H (1995) Role of the lung in accumulation and metabolism of xenobiotic compounds—implications for chemically induced toxicity. Crit Rev Toxicol 25(2):165–205. https://doi.org/10.3109/10408449509021612
2. Shannon VR (2017) Pneumotoxicity associated with immune checkpoint inhibitor therapies. Curr Opin Pulm Med 23(4):305–316. https://doi.org/10.1097/MCP.0000000000000382
3. Murdoch D, Sager J (2008) Will targeted therapy hold its promise? An evidence-based review. Curr Opin Oncol 20(1):104–111. https://doi.org/10.1097/CCO.0b013e3282f44b12
4. Cruz BD, Barbosa MM, Torres LL, Azevedo PS, Silva VEA, Godman B, Alvares-Teodoro J (2021) Crizotinib versus conventional chemotherapy in first-line treatment for ALK-positive non-small cell lung cancer: a systematic review and meta-analysis. Oncol Ther. https://doi.org/10.1007/s40487-021-00155-3
5. Sun L, Guo YJ, Song J, Wang YR, Zhang SL, Huang LT, Zhao JZ, Jing W, Han CB, Ma JT (2021) Neoadjuvant EGFR-TKI therapy for EGFR-mutant NSCLC: a systematic review and pooled analysis of five prospective clinical trials. Front Oncol 10:586596. https://doi.org/10.3389/fonc.2020.586596
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3